Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FRPT - US3580391056 - Common Stock

64.25 USD
+0.99 (+1.56%)
Last: 1/16/2026, 8:20:28 PM
64.83 USD
+0.58 (+0.9%)
After Hours: 1/16/2026, 8:20:28 PM
Fundamental Rating

5

FRPT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 87 industry peers in the Food Products industry. Both the profitability and the financial health of FRPT get a neutral evaluation. Nothing too spectacular is happening here. FRPT is valued quite expensive, but it does show an excellent growth. These ratings would make FRPT suitable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year FRPT was profitable.
  • In the past year FRPT had a positive cash flow from operations.
  • FRPT had negative earnings in 4 of the past 5 years.
  • FRPT had a positive operating cash flow in 4 of the past 5 years.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • FRPT's Return On Assets of 7.07% is amongst the best of the industry. FRPT outperforms 85.06% of its industry peers.
  • With a decent Return On Equity value of 10.48%, FRPT is doing good in the industry, outperforming 78.16% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.28%, FRPT is in line with its industry, outperforming 52.87% of the companies in the same industry.
Industry RankSector Rank
ROA 7.07%
ROE 10.48%
ROIC 3.28%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

  • The Profit Margin of FRPT (11.44%) is better than 89.66% of its industry peers.
  • The Operating Margin of FRPT (6.41%) is better than 66.67% of its industry peers.
  • FRPT has a Gross Margin of 40.58%. This is amongst the best in the industry. FRPT outperforms 91.95% of its industry peers.
  • In the last couple of years the Gross Margin of FRPT has declined.
Industry RankSector Rank
OM 6.41%
PM (TTM) 11.44%
GM 40.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRPT is destroying value.
  • Compared to 1 year ago, FRPT has more shares outstanding
  • Compared to 5 years ago, FRPT has more shares outstanding
  • The debt/assets ratio for FRPT has been reduced compared to a year ago.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.11 indicates that FRPT is not in any danger for bankruptcy at the moment.
  • FRPT's Altman-Z score of 4.11 is amongst the best of the industry. FRPT outperforms 82.76% of its industry peers.
  • The Debt to FCF ratio of FRPT is 176.25, which is on the high side as it means it would take FRPT, 176.25 years of fcf income to pay off all of its debts.
  • FRPT has a Debt to FCF ratio (176.25) which is in line with its industry peers.
  • FRPT has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
  • FRPT's Debt to Equity ratio of 0.36 is in line compared to the rest of the industry. FRPT outperforms 56.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 176.25
Altman-Z 4.11
ROIC/WACC0.41
WACC7.99%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 5.52 indicates that FRPT has no problem at all paying its short term obligations.
  • The Current ratio of FRPT (5.52) is better than 94.25% of its industry peers.
  • A Quick Ratio of 4.61 indicates that FRPT has no problem at all paying its short term obligations.
  • The Quick ratio of FRPT (4.61) is better than 94.25% of its industry peers.
Industry RankSector Rank
Current Ratio 5.52
Quick Ratio 4.61
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 196.63% over the past year.
  • The Revenue has grown by 16.34% in the past year. This is quite good.
  • The Revenue has been growing by 31.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)196.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%675%
Revenue 1Y (TTM)16.34%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%14%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.09% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 10.25% on average over the next years. This is quite good.
EPS Next Y127.26%
EPS Next 2Y24.18%
EPS Next 3Y27.01%
EPS Next 5Y21.09%
Revenue Next Year13.01%
Revenue Next 2Y11.34%
Revenue Next 3Y10.93%
Revenue Next 5Y10.25%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B 2.5B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 24.34, the valuation of FRPT can be described as rather expensive.
  • FRPT's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of FRPT to the average of the S&P500 Index (27.47), we can say FRPT is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 44.32, FRPT can be considered very expensive at the moment.
  • FRPT's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 24.26. FRPT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 24.34
Fwd PE 44.32
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as FRPT.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as FRPT.
Industry RankSector Rank
P/FCF 1292.68
EV/EBITDA 20.59
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as FRPT's earnings are expected to grow with 27.01% in the coming years.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y24.18%
EPS Next 3Y27.01%

0

5. Dividend

5.1 Amount

  • No dividends for FRPT!.
Industry RankSector Rank
Dividend Yield 0%

FRESHPET INC

NASDAQ:FRPT (1/16/2026, 8:20:28 PM)

After market: 64.83 +0.58 (+0.9%)

64.25

+0.99 (+1.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-03
Earnings (Next)02-18
Inst Owners119.68%
Inst Owner Change0.13%
Ins Owners1.82%
Ins Owner Change6.12%
Market Cap3.14B
Revenue(TTM)1.08B
Net Income(TTM)123.44M
Analysts75.83
Price Target74.64 (16.17%)
Short Float %12.24%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)238.72%
Min EPS beat(2)157.12%
Max EPS beat(2)320.31%
EPS beat(4)2
Avg EPS beat(4)114.73%
Min EPS beat(4)-9.66%
Max EPS beat(4)320.31%
EPS beat(8)6
Avg EPS beat(8)167.24%
EPS beat(12)9
Avg EPS beat(12)116.75%
EPS beat(16)9
Avg EPS beat(16)71.21%
Revenue beat(2)0
Avg Revenue beat(2)-1.76%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-0.37%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)-0.37%
Revenue beat(8)3
Avg Revenue beat(8)-0.27%
Revenue beat(12)5
Avg Revenue beat(12)0.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.09%
PT rev (1m)0.41%
PT rev (3m)-20.31%
EPS NQ rev (1m)-11.85%
EPS NQ rev (3m)-35.56%
EPS NY rev (1m)10.6%
EPS NY rev (3m)90.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.62%
Valuation
Industry RankSector Rank
PE 24.34
Fwd PE 44.32
P/S 2.91
P/FCF 1292.68
P/OCF 20.13
P/B 2.66
P/tB 2.66
EV/EBITDA 20.59
EPS(TTM)2.64
EY4.11%
EPS(NY)1.45
Fwd EY2.26%
FCF(TTM)0.05
FCFY0.08%
OCF(TTM)3.19
OCFY4.97%
SpS22.12
BVpS24.14
TBVpS24.14
PEG (NY)0.19
PEG (5Y)N/A
Graham Number37.87
Profitability
Industry RankSector Rank
ROA 7.07%
ROE 10.48%
ROCE 4.15%
ROIC 3.28%
ROICexc 3.92%
ROICexgc 3.92%
OM 6.41%
PM (TTM) 11.44%
GM 40.58%
FCFM 0.22%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
F-Score8
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 176.25
Debt/EBITDA 2.7
Cap/Depr 173.99%
Cap/Sales 14.21%
Interest Coverage 8.38
Cash Conversion 99%
Profit Quality 1.97%
Current Ratio 5.52
Quick Ratio 4.61
Altman-Z 4.11
F-Score8
WACC7.99%
ROIC/WACC0.41
Cap/Depr(3y)442.82%
Cap/Depr(5y)604.48%
Cap/Sales(3y)29.67%
Cap/Sales(5y)41.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)196.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%675%
EPS Next Y127.26%
EPS Next 2Y24.18%
EPS Next 3Y27.01%
EPS Next 5Y21.09%
Revenue 1Y (TTM)16.34%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%14%
Revenue Next Year13.01%
Revenue Next 2Y11.34%
Revenue Next 3Y10.93%
Revenue Next 5Y10.25%
EBIT growth 1Y94.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year379.26%
EBIT Next 3Y89.29%
EBIT Next 5Y54.32%
FCF growth 1Y101.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y215.31%
OCF growth 3Y519.17%
OCF growth 5Y56.72%

FRESHPET INC / FRPT FAQ

What is the ChartMill fundamental rating of FRESHPET INC (FRPT) stock?

ChartMill assigns a fundamental rating of 5 / 10 to FRPT.


What is the valuation status for FRPT stock?

ChartMill assigns a valuation rating of 3 / 10 to FRESHPET INC (FRPT). This can be considered as Overvalued.


How profitable is FRESHPET INC (FRPT) stock?

FRESHPET INC (FRPT) has a profitability rating of 5 / 10.


What is the valuation of FRESHPET INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESHPET INC (FRPT) is 24.34 and the Price/Book (PB) ratio is 2.66.


How financially healthy is FRESHPET INC?

The financial health rating of FRESHPET INC (FRPT) is 6 / 10.